169 related articles for article (PubMed ID: 32068098)
1. Serum cortisol level after low dose dexamethasone suppression test may be predictive for diabetes mellitus and hypertension presence in obese patients: A retrospective study.
Hepsen S; Sencar E; Sakiz D; Akhanli P; Ucan B; Unsal I; Ozbek M; Cakal E
Diabetes Res Clin Pract; 2020 Mar; 161():108081. PubMed ID: 32068098
[TBL] [Abstract][Full Text] [Related]
2. Which type 2 diabetes mellitus patients should be screened for subclinical Cushing's syndrome?
Cansu GB; Atılgan S; Balcı MK; Sarı R; Özdem S; Altunbaş HA
Hormones (Athens); 2017 Jan; 16(1):22-32. PubMed ID: 28500825
[TBL] [Abstract][Full Text] [Related]
3. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study.
Pasquali R; Ambrosi B; Armanini D; Cavagnini F; Uberti ED; Del Rio G; de Pergola G; Maccario M; Mantero F; Marugo M; Rotella CM; Vettor R;
J Clin Endocrinol Metab; 2002 Jan; 87(1):166-75. PubMed ID: 11788642
[TBL] [Abstract][Full Text] [Related]
4. Obstructive sleep apnea syndrome causes a pseudo-Cushing's state in Japanese obese patients with type 2 diabetes mellitus.
Tamada D; Otsuki M; Kashine S; Hirata A; Onodera T; Kitamura T; Shimomura I
Endocr J; 2013; 60(12):1289-94. PubMed ID: 24047562
[TBL] [Abstract][Full Text] [Related]
5. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
Putignano P; Bertolini M; Losa M; Cavagnini F
J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks.
Morelli V; Palmieri S; Lania A; Tresoldi A; Corbetta S; Cairoli E; Eller-Vainicher C; Arosio M; Copetti M; Grossi E; Chiodini I
Eur J Endocrinol; 2017 Jul; 177(1):73-83. PubMed ID: 28468767
[TBL] [Abstract][Full Text] [Related]
7. Pulsatile human corticotropin-releasing hormone prevents dexamethasone-induced suppression of the plasma cortisol response to hypoglycemia in normal men.
Avgerinos PC; Kiamouris CK; Petrakos IP; Kleanthous IK; Zorzos PA; Dimitriadis TN; Raptis SA; Cutler GB
J Clin Endocrinol Metab; 1992 Nov; 75(5):1358-61. PubMed ID: 1331166
[TBL] [Abstract][Full Text] [Related]
8. Acute administration of buspirone increases the escape of hypothalamic-pituitary-adrenal-axis hormones from suppression by dexamethasone in depression.
Maes M; Van Gastel A; Meltzer HY; Cosyns P; Blockx P; Desnyder R
Psychoneuroendocrinology; 1996 Jan; 21(1):67-81. PubMed ID: 8778905
[TBL] [Abstract][Full Text] [Related]
9. The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors.
Favero V; Aresta C; Parazzoli C; Cairoli E; Eller-Vainicher C; Palmieri S; Salcuni AS; Arosio M; Persani L; Scillitani A; Morelli V; Chiodini I
Cardiovasc Diabetol; 2023 May; 22(1):102. PubMed ID: 37131218
[TBL] [Abstract][Full Text] [Related]
10. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke.
Rosmond R; Björntorp P
J Intern Med; 2000 Feb; 247(2):188-97. PubMed ID: 10692081
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
[TBL] [Abstract][Full Text] [Related]
12. Relationship Between Overnight Dexamethasone Suppression Test and Aging.
Ciftel S; Mercantepe F
Cureus; 2023 Nov; 15(11):e48383. PubMed ID: 38060754
[TBL] [Abstract][Full Text] [Related]
13. The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test.
Arruda M; Mello Ribeiro Cavalari E; Pessoa de Paula M; Fernandes Cordeiro de Morais F; Furtado Bilro G; Alves Coelho MC; de Oliveira E Silva de Morais NA; Choeri D; Moraes A; Vieira Neto L
J Hum Hypertens; 2017 Dec; 32(1):3-11. PubMed ID: 29176595
[TBL] [Abstract][Full Text] [Related]
14. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
[TBL] [Abstract][Full Text] [Related]
15. Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol.
Putignano P; Dubini A; Toja P; Invitti C; Bonfanti S; Redaelli G; Zappulli D; Cavagnini F
Eur J Endocrinol; 2001 Aug; 145(2):165-71. PubMed ID: 11454512
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 1 mg versus 2 mg Dexamethasone Suppression Test in Patients with Obesity.
Urwyler SA; Cupa N; Christ-Crain M
Horm Metab Res; 2017 Nov; 49(11):854-859. PubMed ID: 28962047
[TBL] [Abstract][Full Text] [Related]
17. Interpretation of Abnormal Dexamethasone Suppression Test is Enhanced With Use of Synchronous Free Cortisol Assessment.
Genere N; Kaur RJ; Athimulam S; Thomas MA; Nippoldt T; Van Norman M; Singh R; Grebe S; Bancos I
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1221-e1230. PubMed ID: 34648626
[TBL] [Abstract][Full Text] [Related]
18. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
Ueland GÅ; Methlie P; Kellmann R; Bjørgaas M; Åsvold BO; Thorstensen K; Kelp O; Thordarson HB; Mellgren G; Løvås K; Husebye ES
Eur J Endocrinol; 2017 Jun; 176(6):705-713. PubMed ID: 28298353
[TBL] [Abstract][Full Text] [Related]
20. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL.
Araujo-Castro M; Parra Ramírez P; Martín Rojas-Marcos P; García Centeno R; Gracia Gimeno P; Tomé Fernández-Ladreda M; Sampedro Núñez MA; Higueruela C; Robles Lázaro C
Endocrine; 2023 Feb; 79(2):384-391. PubMed ID: 36261701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
